NEW YORK, NY, February 6, 2024 — Research Published in Nature Communications and Funded in Part by the Lupus Research Alliance Could Correct a Defect in Lupus Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious […] READ MORE
NEW YORK, NY, January 30, 2024 — Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will […] READ MORE
NEW YORK, NY, November 21, 2023 – This year’s Lupus Research Alliance (LRA) Breaking Through Gala raised $2 million for lupus research and brought the hope of tremendous progress that’s improving lupus treatment while driving to a cure. The annual celebration began with a powerhouse performance and moving tribute to lupus warriors by multi-talented pianist, […] READ MORE
SAN DIEGO, CA, Nov. 6, 2023 – This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part of, the American College of Rheumatology. 30+ presentations of studies funded by the LRA spanning a broad spectrum of research areas Positive results from Phase 2/3 clinical studies supported […] READ MORE
NEW YORK, NY, October 26, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced successful results of the Patient Advocates for Lupus Studies (PALS) pilot study that were published in ACR Open Rheumatology. The study showed that 12 months after finishing the PALS program, participants’ knowledge about lupus clinical trials had […] READ MORE
NEW YORK, NY, October 24, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with AbbVie Inc. for the Phase 3 development of upadacitinib (RINVOQ®) as a potential treatment for people living with systemic lupus erythematosus (SLE). Lupus Therapeutics will assist with recruiting participants to join the study, […] READ MORE
NEW YORK, NY, October 20, 2023 — Thousands of supporters will join together Saturday, October 21 at the Intrepid Museum (formerly called the Intrepid Sea, Air and Space Museum) to celebrate the 20th Anniversary of the Lupus Research Alliance (LRA) 2023 New York City Walk with Us to Cure Lupus. Registration remains open through Walk Day at www.lupuswalknyc.org. While the well-attended annual […] READ MORE
NEW YORK, NY, October 17, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with the biopharmaceutical company Nkarta, Inc. in developing the engineered natural killer (NK) cell therapy NKX019 as a potential treatment for people with refractory lupus nephritis who have not responded to standard treatment. READ MORE
NEW YORK, NY, August 2, 2023 — The Lupus Research Alliance (LRA) is pleased to announce that the 2023 Global Team Science Award (GTSA) has been granted to an exceptional multidisciplinary research team of experts in immunology, pediatric rheumatology and nephrology, genetics, and data analysis to identify drivers of lupus nephritis in children with the […] READ MORE
SUMMIT, NJ, July 17, 2023 — Former Super Bowl Champion and Mad Dog Sports radio personality Willie Colon is hosting today the 9th Annual Willie Colon Golf Outing crafted by Tito’s Handmade Vodka for the Lupus Research Alliance (LRA). The event drives lupus awareness and tees up the opening of the Fall season of the […] READ MORE
NEW YORK, NY, July 12, 2023 — The Lupus Research Alliance is pleased to announce the 2023 recipients of the Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Awards aim to foster the development of outstanding, underrepresented minority scientists and establish a diverse community of researchers and […] READ MORE
NEW YORK, NY, June 29, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, launched three pilot research initiatives for Project CHANGE, a community-driven approach to address systemic challenges contributing to the underrepresentation of people of color, particularly Black people, in lupus clinical trials. Emory University in Atlanta, Vanderbilt University in Nashville, […] READ MORE
